Ameritas Investment Partners, Inc. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$919,679
-26.7%
34,227
-2.7%
0.04%
-21.3%
Q2 2023$1,253,877
+39.1%
35,162
-0.9%
0.05%
+30.6%
Q1 2023$901,243
-22.3%
35,4820.0%0.04%
-21.7%
Q4 2022$1,160,261
-1.3%
35,482
-0.2%
0.05%
-13.2%
Q3 2022$1,175,000
-7.5%
35,555
-1.5%
0.05%
-3.6%
Q2 2022$1,270,000
-23.5%
36,0970.0%0.06%
-8.3%
Q1 2022$1,660,000
-29.5%
36,097
+1.6%
0.06%
-24.1%
Q4 2021$2,356,000
+6.2%
35,5420.0%0.08%
-2.5%
Q3 2021$2,219,000
-25.7%
35,542
-1.5%
0.08%
-24.3%
Q2 2021$2,988,000
+22.4%
36,081
-2.0%
0.11%
+15.1%
Q1 2021$2,441,000
-13.6%
36,8070.0%0.09%
-28.5%
Q4 2020$2,824,000
+74.1%
36,807
-2.3%
0.13%
+78.1%
Q3 2020$1,622,000
-1.6%
37,672
-1.3%
0.07%
-7.6%
Q2 2020$1,648,000
+55.8%
38,155
+3.7%
0.08%
+31.7%
Q1 2020$1,058,000
-53.9%
36,790
+1.6%
0.06%
-41.2%
Q4 2019$2,296,000
+953.2%
36,197
+367.3%
0.10%
+920.0%
Q3 2019$218,000
+6.3%
7,7460.0%0.01%
+11.1%
Q2 2019$205,000
+44.4%
7,7460.0%0.01%
+28.6%
Q1 2019$142,000
+57.8%
7,746
+6.8%
0.01%
+40.0%
Q4 2018$90,000
-35.3%
7,2560.0%0.01%
-16.7%
Q3 2018$139,000
+40.4%
7,2560.0%0.01%
+20.0%
Q2 2018$99,000
+1000.0%
7,256
+56.1%
0.01%
Q1 2017$9,0004,6480.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,346$62,945,00041.38%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$250,206,00032.27%
Aquilo Capital Management, LLC 365,926$28,078,0005.84%
L1 Capital Pty Ltd 298,687$23,127,0004.32%
First Light Asset Management, LLC 704,449$54,052,0004.00%
ACUTA CAPITAL PARTNERS, LLC 139,000$10,665,0002.90%
Evolutionary Tree Capital Management, LLC 48,265$3,703,0002.82%
Parkman Healthcare Partners LLC 127,171$9,758,0002.50%
Capital Impact Advisors, LLC 88,183$6,766,0001.66%
Tri Locum Partners LP 56,003$4,297,0001.56%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders